Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998 Dec;31(6):516-20.
doi: 10.1002/(sici)1096-911x(199812)31:6<516::aid-mpo9>3.0.co;2-q.

Results of intensive chemotherapy in children with juvenile chronic myelomonocytic leukemia: a pilot study

Affiliations

Results of intensive chemotherapy in children with juvenile chronic myelomonocytic leukemia: a pilot study

C Díaz de Heredia et al. Med Pediatr Oncol. 1998 Dec.

Abstract

Background: The use of chemotherapy in juvenile chronic myelomonocytic leukemia (J-CMML) has not generally been successful. Our previous experience in 11 patients demonstrated that chemotherapy with low doses of daunorubicin or cytarabine resulted in a 90% fatal outcome and a median survival rate of only 7 months.

Procedure and results: Between 1985 and 1997, six children (five boys and one girl) aged 3-67 months (median age: 20.5) were diagnosed with J-CMML and underwent intensive combination chemotherapy similar to that used for acute myeloblastic leukemia. Two patients with high-risk factors developed progressive disease with fatal outcome at 5 and 18 months postdiagnosis, respectively. However, four patients without poor prognosis indices responded and were alive 145, 82, 51, and 6 months after diagnosis. Overall survival in this small series at 7 years from diagnosis is 60% (CI: 17-100).

Conclusions: The use of intensive combination chemotherapy in children with J-CMML can result in long-term survival in some patients.

PubMed Disclaimer

LinkOut - more resources